These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 4752586

  • 1. [Treatment of threatened premature labor. Clinical observations with toxicologic drugs].
    Vangen O.
    Tidsskr Nor Laegeforen; 1973 Apr 30; 93(12):850-2. PubMed ID: 4752586
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The treatment of late abortion and of threatened premature birth with Th 1165 a combined with Isoptin (author's transl)].
    Weidinger H, Wiest W.
    Z Geburtshilfe Perinatol; 1973 Aug 30; 177(4):233-7. PubMed ID: 4149060
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of early threatened abortion (6th-16th week of pregnancy) using a new tocolytic agent (Th 1165a)].
    Bärmig H, Krzoska C.
    Zentralbl Gynakol; 1974 Jan 11; 96(2):55-8. PubMed ID: 4606038
    [No Abstract] [Full Text] [Related]

  • 5. [The influence of a tocolytic therapy with Th 1165 a on the excretion of total oestrogens in urine in the second half of pregnancy (author's transl)].
    Jütting G, Austermann R, Barényi W, Biemann-Hochstrate C.
    Z Geburtshilfe Perinatol; 1973 Oct 11; 177(5):356-66. PubMed ID: 4777493
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical studies with a new tocolytic agent (Th 1165 a). Contribution to the management of threatening premature labor].
    Schmidt J, Hirdes G.
    Zentralbl Gynakol; 1973 Mar 16; 95(11):361-9. PubMed ID: 4716652
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The effect of the calcium inhibitors verapamil (Isoptin) und D 600 on the side effects of the inhibition of labour with the beta-adrenergic drug Th 1165 a (Partusisten)].
    Neubüser D.
    Geburtshilfe Frauenheilkd; 1974 Sep 16; 34(9):782-7. PubMed ID: 4155046
    [No Abstract] [Full Text] [Related]

  • 10. [Partusisten in obstetrics].
    Zahn V, Johannigmann J.
    Zentralbl Gynakol; 1975 Sep 16; 97(10):605-11. PubMed ID: 1189750
    [Abstract] [Full Text] [Related]

  • 11. [Indications and results of uterine tocolysis].
    Koepcke E, Seidenschnur G.
    Zentralbl Gynakol; 1974 Feb 15; 96(7):193-202. PubMed ID: 4207856
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prevention of premature birth by uterus-inhibiting drugs].
    Lowenberg E, Vargas García C, Rodríguez C.
    Ginecol Obstet Mex; 1981 Jun 15; 49(296):377-91. PubMed ID: 6124485
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Aspects of the therapy of threatened premature labor].
    Unbehaun V, Conradt A, Meiswinkel E.
    Med Welt; 1972 Dec 16; 23(51):1920-2. PubMed ID: 4145263
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical use of orciprenaline as an inhibitor of uterine contractility].
    Soto Yances A.
    Rev Colomb Obstet Ginecol; 1970 Dec 16; 21(3):219-31. PubMed ID: 5505816
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.